Close Menu

NEW YORK – Exact Sciences announced today that it has entered into a deal to acquire Genomic Health for $2.8 billion in cash and stock.

In a separate announcement, the company reported its second quarter earnings rose 94 percent year over year, due to a 93 percent increase in testing volumes from its Cologuard colorectal cancer diagnostic.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.